The Role of Genetic Variants in the Association between Dietary Acrylamide and Advanced Prostate Cancer in the Netherlands Cohort Study on Diet and Cancer

References

• Brawer MK: Hormonal therapy for prostate cancer. Rev Urol 8(Suppl 2), S35–S47, 2006.
   PubMedGoogle Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5), E359–E386, 2015. doi:10.1002/ijc.29210.
   PubMed Web of Science ®Google Scholar
• Discacciati A, and Wolk A: Lifestyle and dietary factors in prostate cancer prevention. Recent Results Cancer Res 202, 27–37, 2014. doi:10.1007/978-3-642-45195-9_3.
   PubMedGoogle Scholar
• Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, et al.: Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer 138(6), 1388–1400, 2016. doi:10.1002/ijc.29894.
   PubMed Web of Science ®Google Scholar
• Cook LS, Goldoft M, Schwartz SM, and Weiss NS: Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 161, 152–155, 1999.
   PubMed Web of Science ®Google Scholar
• Kimura T: East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer 31(9), 421–429, 2012. doi:10.5732/cjc.011.10324.
   PubMed Web of Science ®Google Scholar
• Pelucchi C, Bosetti C, Galeone C, and La Vecchia C: Dietary acrylamide and cancer risk: an updated meta-analysis. Int J Cancer 136(12), 2912–2922, 2015. doi:10.1002/ijc.29339.
   PubMed Web of Science ®Google Scholar
• Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA: Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr 87, 1428–1438, 2008.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Akesson A, and Wolk A: Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 18(6), 1939–1941, 2009. doi:10.1158/1055-9965.epi-09-0280.
   PubMed Web of Science ®Google Scholar
• Wilson KM, Giovannucci E, Stampfer MJ, and Mucci LA: Dietary acrylamide and risk of prostate cancer. Int J Cancer 131(2), 479–487, 2012. doi:10.1002/ijc.26383.
   PubMed Web of Science ®Google Scholar
• Besaratinia A, and Pfeifer GP: A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 28(3), 519–528, 2007. doi:10.1093/carcin/bgm006.
   PubMed Web of Science ®Google Scholar
• Besaratinia A, and Pfeifer GP: Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst 96, 1023–1029, 2004.
   PubMed Web of Science ®Google Scholar
• Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA: A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev 16(11), 2304–2313, 2007. doi:10.1158/1055-9965.epi-07-0581.
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, and Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11), 1603–1616, 2010. doi:10.1016/j.freeradbiomed.2010.09.006.
   PubMed Web of Science ®Google Scholar
• Finkel T, and Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–247, 2000. doi:10.1038/35041687.
   PubMed Web of Science ®Google Scholar
• Khandrika L, Kumar B, Koul S, Maroni P, and Koul HK: Oxidative stress in prostate cancer. Cancer Lett 282(2), 125–136, 2009. doi:10.1016/j.canlet.2008.12.011.
   PubMed Web of Science ®Google Scholar
• Kulathinal S, Karvanen J, Saarela O, and Kuulasmaa K: Case-cohort design in practice – experiences from the MORGAM Project. Epidemiol Perspect Innov 4, 15, 2007. doi:10.1186/1742-5573-4-15.
   PubMedGoogle Scholar
• Van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, and Hunen PM: Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 19, 553–558, 1990.
   PubMed Web of Science ®Google Scholar
• van den Brandt PA, Goldbohm RA, van 't Veer P, Volovics A, Hermus RJ, et al.: A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 43, 285–295, 1990.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Gospodarowicz MK, and Wittekind C: TNM Classification of Malignant Tumors, 7th ed. Oxford, UK: Wiley-Blackwell; 2009.
   Google Scholar
• Goldbohm RA, van den Brandt PA, Brants HA, van't Veer P, Al M, et al.: Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 48, 253–265, 1994.
   PubMed Web of Science ®Google Scholar
• Goldbohm RA, van 't Veer P, van den Brandt PA, van 't Hof MA, Brants HA, et al.: Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 49, 420–429, 1995.
   PubMed Web of Science ®Google Scholar
• Konings EJ, Hogervorst JG, van Rooij L, Schouten LJ, Sizoo EA, et al.: Validation of a database on acrylamide for use in epidemiological studies. Eur J Clin Nutr 64, 534–540, 2010. doi:10.1038/ejcn.2010.17.
   PubMed Web of Science ®Google Scholar
• Hogervorst JG, van den Brandt PA, Godschalk RW, van Schooten FJ, and Schouten LJ: The influence of single nucleotide polymorphisms on the association between dietary acrylamide intake and endometrial cancer risk. Sci Rep 6(34902), 2016. doi:10.1038/srep34902.
   Web of Science ®Google Scholar
• Huang YF, Chen ML, Liou SH, Chen MF, Uang SN, et al.: Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide. Toxicol Lett 203(2), 118–126, 2011. doi:10.1016/j.toxlet.2011.03.008.
   PubMed Web of Science ®Google Scholar
• Hogervorst JG, Godschalk RW, van den Brandt PA, Weijenberg MP, Verhage BA, et al.: DNA from nails for genetic analyses in large-scale epidemiologic studies. Cancer Epidemiol Biomarkers Prev 23(12), 2703–2712, 2014. doi:10.1158/1055-9965.epi-14-0552.
   PubMed Web of Science ®Google Scholar
• Gabriel S, Ziaugra L, and Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter 2, Unit 2.12, 2009. doi:10.1002/0471142905.hg0212s60.
   PubMedGoogle Scholar
• Benjamini Y, and Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 57, 289–300, 1995.
   Web of Science ®Google Scholar
• Lin DY, and Wei LJ: The robust inference for the cox proportional hazards model. J Am Stat Assoc 84(408), 1074–1078, 1989. doi:10.2307/2290085.
   Web of Science ®Google Scholar
• Schoenfeld D: Partial residuals for the proportional hazards regression model. Biometrika 69(1), 239–241, 1982. doi:10.2307/2335876.
   Web of Science ®Google Scholar
• Huncharek M, Haddock KS, Reid R, and Kupelnick B: Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 100(4), 693–701, 2010. doi:10.2105/ajph.2008.150508.
   PubMed Web of Science ®Google Scholar
• Islami F, Moreira DM, Boffetta P, and Freedland SJ: A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol 66(6), 1054–1064, 2014. doi:10.1016/j.eururo.2014.08.059.
   PubMed Web of Science ®Google Scholar
• Geybels MS, van den Brandt PA, Schouten LJ, van Schooten FJ, van Breda SG, et al.: Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer. J Natl Cancer Inst 106, dju003, 2014. doi:10.1093/jnci/dju003.
   PubMedGoogle Scholar
• Geybels MS, van den Brandt PA, van Schooten FJ, and Verhage BA: Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 24(1), 178–186, 2015. doi:10.1158/1055-9965.epi-14-0968.
   PubMed Web of Science ®Google Scholar
• Liou GY, and Storz P: Reactive oxygen species in cancer. Free Radic Res 44(5), 479–496, 2010. doi:10.3109/10715761003667554.
   PubMed Web of Science ®Google Scholar
• Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, et al.: Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 23, 1037–1046, 2014. doi:10.1158/1055-9965.EPI-13-0670.
   PubMed Web of Science ®Google Scholar
• Stack E, and DuBois RN: Regulation of cyclo-oxygenase-2. Best Pract Res Clin Gastroenterol 15(5), 787–800, 2001. doi:10.1053/bega.2001.0235.
   PubMed Web of Science ®Google Scholar
• Uotila P, Valve E, Martikainen P, Nevalainen M, Nurmi M, et al.: Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol Res 29(1), 23–28, 2001.
   Google Scholar
• Yang X, Li B, Si T, Liu Y, and Guo Z: Association between the 8473T>C polymorphism of PTGS2 and prostate cancer risk: a metaanalysis including 24,716 subjects. Onkologie 36(4), 182–186, 2013. doi:10.1159/000349951.
   PubMedGoogle Scholar
• Hu Z, Miao X, Ma H, Wang X, Tan W, et al.: A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 48(1), 11–17, 2005. doi:10.1016/j.lungcan.2004.09.004.
   PubMed Web of Science ®Google Scholar
• Yang H, Gu J, Lin X, Grossman HB, Ye Y, et al.: Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Clin Cancer Res 14(7), 2236–2244, 2008. doi:10.1158/1078-0432.ccr-07-1670.
   PubMed Web of Science ®Google Scholar
• Melis JP, Luijten M, Mullenders LH, and van Steeg H: The role of XPC: implications in cancer and oxidative DNA damage. Mutat Res 728(3), 107–117, 2011. doi:10.1016/j.mrrev.2011.07.001.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhong H, Gao JG, Tang JE, and Wang R: A systematic review and meta-analysis of three gene variants association with risk of prostate cancer: an update. Urol J 12(3), 2138–2147, 2015.
   Web of Science ®Google Scholar
• Francisco G, Menezes PR, Eluf-Neto J, and Chammas R: XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet 16(6), 724–734, 2008. doi:10.1038/ejhg.2008.6.
   PubMed Web of Science ®Google Scholar
• Goldbohm RA, van den Brandt PA, and Dorant E: Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr Soc Gezondheidsz 72, 80–84, 1994.
   Google Scholar